News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China
Raffaele Colombo/LinkedIn
Mar 11, 2025, 09:56

Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X:

“Sacituzumab tirumotecan approved for a second indication by NMPA in China:

for the treatment of adult patients with EGFR-mutant locally advanced or metastatic non-squamous NSCLC following progression on EGFR-tyrosine kinase inhibitor therapy and platinum-based chemotherapy.”

Raffaele Colombo

cancer OncoDaily Oncology Raffaele Colombo Sacituzumab Tirumotecan
Special Coverage
Blog
Apr 15, 2025, 12:34
Chandler Park: Great privilege to advocate for cancer patients at the 2025 ASCO Advocacy Summit
Societies
Apr 15, 2025, 12:34
American Cancer Society Cancer Action Network launched 2025 annual Giving Week
Blog
Apr 15, 2025, 12:29
Wafaa M Rashed: Mutaz Mohamed on the urgent need to expand affordable genetic testing across African nations
Blog
Apr 15, 2025, 12:23
Conquer Cancer - Julie Gralow discusses how aspiring grant makers can utilize grant management services
Societies
Apr 15, 2025, 12:21
The Pediatric Oncology East and Mediterranean Group's (POEM) 4th Scientific Meeting
Blog
Apr 15, 2025, 12:18
Erick Mahatara: Almost 75% deaths in the world are due to NCDs, and the urgency around these diseases still seems too low
Blog
Apr 15, 2025, 12:17
Bernard A. Fox: Great commentary from Nature Medicine on vaccine hesitancy and the threat presented by the new leadership of HHS
Blog
Apr 15, 2025, 12:17
Duke Radiation Oncology - Olivia Franek presenting radiation oncology patient education videos project at ONS Congress
Blog
Apr 15, 2025, 12:08
Luis Lara-Mejía: Oncogenic fusions represent a diagnostic challenge across solid tumors
Blog
Apr 15, 2025, 12:02
Early registration is closing for the ESMO Gynaecological Cancers 2025
Blog
Apr 15, 2025, 11:54
Esosa Omoregie: Day 2 at ASBMB 2025 - Insights, networking, and career growth
Blog
Apr 15, 2025, 11:52
Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC